A. Soleiman

1.2k total citations
19 papers, 919 citations indexed

About

A. Soleiman is a scholar working on Molecular Biology, Nephrology and Rheumatology. According to data from OpenAlex, A. Soleiman has authored 19 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Rheumatology. Recurrent topics in A. Soleiman's work include Renal Diseases and Glomerulopathies (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Renal Transplantation Outcomes and Treatments (2 papers). A. Soleiman is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Renal Transplantation Outcomes and Treatments (2 papers). A. Soleiman collaborates with scholars based in Austria, United States and Germany. A. Soleiman's co-authors include Dontscho Kerjaschki, Silvana Breiteneder-Geleff, Paul Meraner, K. Matsui, Romana Kalt, G Schäffner, Ludwig Erlacher, W. Graninger, Klaus Bobacz and Reinhard Gruber and has published in prestigious journals such as CHEST Journal, Annals of the Rheumatic Diseases and Osteoarthritis and Cartilage.

In The Last Decade

A. Soleiman

17 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Soleiman Austria 12 424 290 285 153 138 19 919
Orhan G. Yigitbasi Türkiye 18 323 0.8× 187 0.6× 303 1.1× 286 1.9× 36 0.3× 49 982
Luis F de Castro United States 19 392 0.9× 105 0.4× 495 1.7× 67 0.4× 77 0.6× 45 1.1k
Shamlal Mangray United States 19 441 1.0× 459 1.6× 262 0.9× 223 1.5× 204 1.5× 56 1.2k
Pierre Guihard France 12 189 0.4× 152 0.5× 422 1.5× 109 0.7× 72 0.5× 24 1.0k
Steve Kaufman United States 7 449 1.1× 85 0.3× 591 2.1× 119 0.8× 93 0.7× 10 1.0k
Iwao Nakayama Japan 19 282 0.7× 420 1.4× 239 0.8× 169 1.1× 26 0.2× 92 1.2k
Takenori Ozaki Japan 15 77 0.2× 182 0.6× 224 0.8× 121 0.8× 180 1.3× 23 662
Jesús Álvarez Spain 17 302 0.7× 100 0.3× 692 2.4× 67 0.4× 59 0.4× 18 1.3k
Beata Bode‐Lesniewska Switzerland 20 341 0.8× 310 1.1× 368 1.3× 546 3.6× 37 0.3× 76 1.4k
Guiti Z. Eghbali-Fatourechi United States 7 190 0.4× 145 0.5× 310 1.1× 69 0.5× 35 0.3× 7 719

Countries citing papers authored by A. Soleiman

Since Specialization
Citations

This map shows the geographic impact of A. Soleiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Soleiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Soleiman more than expected).

Fields of papers citing papers by A. Soleiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Soleiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Soleiman. The network helps show where A. Soleiman may publish in the future.

Co-authorship network of co-authors of A. Soleiman

This figure shows the co-authorship network connecting the top 25 collaborators of A. Soleiman. A scholar is included among the top collaborators of A. Soleiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Soleiman. A. Soleiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Soleiman, A., et al.. (2024). MYASTHENIA GRAVIS UNMASKED IN A CASE OF IMMUNE CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS AND MYOSITIS. CHEST Journal. 166(4). A2171–A2172.
2.
3.
Bagó-Horváth, Zsuzsanna, Nicolas Kozakowski, A. Soleiman, et al.. (2012). The cutting (w)edge--comparative evaluation of renal baseline biopsies obtained by two different methods. Nephrology Dialysis Transplantation. 27(8). 3241–3248. 16 indexed citations
4.
Haider, Dominik G., Slobodan Peric, Alexander Friedl, et al.. (2011). Kidney biopsy in patients with diabetes mellitus. Clinical Nephrology. 76(9). 180–185. 23 indexed citations
5.
Kozakowski, Nicolas, Georg A. Böhmig, Markus Exner, et al.. (2009). Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome. Nephrology Dialysis Transplantation. 24(6). 1979–1986. 24 indexed citations
6.
Ankersmit, Hendrik Jan, Konrad Höetzenecker, A. Soleiman, et al.. (2009). Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. European Journal of Clinical Investigation. 39(6). 445–456. 52 indexed citations
7.
Soleiman, A., Stefan Hacker, Klaus Aumayr, et al.. (2008). Myocardial lipofuscin‐laden lysosomes contain the apoptosis marker caspase‐cleaved cytokeratin‐18. European Journal of Clinical Investigation. 38(10). 708–712. 9 indexed citations
8.
Polzer, K, A. Soleiman, Wolfgang Baum, et al.. (2007). Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKα. Annals of the Rheumatic Diseases. 67(5). 602–608. 17 indexed citations
9.
10.
Thonhofer, René, et al.. (2006). Decrease of proteinuria in a patient with adult‐onset Still's disease and glomerulonephritis after anti‐TNFα therapy. Scandinavian Journal of Rheumatology. 35(6). 485–488. 11 indexed citations
11.
Haas, Martin, et al.. (2004). A rare cause of anemia due to intestinal tuberculosis in a renal transplant recipient. Clinical Nephrology. 62(8). 158–161. 8 indexed citations
12.
Neumann, Irmgard, et al.. (2004). Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrology Dialysis Transplantation. 20(1). 96–104. 79 indexed citations
13.
Bobacz, Klaus, Reinhard Gruber, A. Soleiman, et al.. (2003). Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis & Rheumatism. 48(9). 2501–2508. 71 indexed citations
14.
Kaczirek, Klaus, A. Soleiman, Martin Schindl, et al.. (2003). Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism. European Journal of Clinical Investigation. 33(6). 488–492. 43 indexed citations
15.
Bobacz, Klaus, A. Soleiman, Ludwig Erlacher, Josef S Smolen, & W. Graninger. (2003). Chondrocyte number and proteoglycan synthesis in the ageing and osteoarthritic human articular cartilage. Arthritis Research. 5(Suppl 1). 94–94. 1 indexed citations
16.
Bobacz, Klaus, Reinhard Gruber, A. Soleiman, et al.. (2002). Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthritis and Cartilage. 10(5). 394–401. 60 indexed citations
17.
Bobacz, Klaus, A. Soleiman, W. Graninger, & Ludwig Erlacher. (2001). Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytes. Arthritis Research & Therapy. 3(S2). 7 indexed citations
18.
Breiteneder-Geleff, Silvana, A. Soleiman, Reinhard Horvat, et al.. (1999). [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].. PubMed. 83. 270–5. 73 indexed citations
19.
Breiteneder-Geleff, Silvana, K. Matsui, A. Soleiman, et al.. (1997). Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.. PubMed. 151(4). 1141–52. 421 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orhan G. Yigitbasi Breakdown of academic impact, for papers by Luis F de Castro Breakdown of academic impact, for papers by Shamlal Mangray Breakdown of academic impact, for papers by Pierre Guihard Breakdown of academic impact, for papers by Steve Kaufman Breakdown of academic impact, for papers by Iwao Nakayama Breakdown of academic impact, for papers by Takenori Ozaki Breakdown of academic impact, for papers by Jesús Álvarez Breakdown of academic impact, for papers by Beata Bode‐Lesniewska Breakdown of academic impact, for papers by Guiti Z. Eghbali-Fatourechi
Rankless by CCL
2026